Literature DB >> 10620711

A kinetic study of the oxidation effects of amphotericin B on human low-density lipoproteins.

J Barwicz1, I Gruda, P Tancrède.   

Abstract

The UV-visible results of this kinetic study show that amphothericin B as Fungizone is a much stronger oxidant than CuSO(4), itself a powerful oxidant of low-density lipoprotein (LDL). Amphotericin B as AmBisome alone has no oxidizing effect on LDL while a mixture of both AmBisome and CuSO(4) induces an important potentialization of the LDL oxidation. These results allow us to believe that the high toxicity of amphotericin B is related to its capacity to modify and to weaken the structure of LDL. In addition, differential scanning calorimetry experiments show that the oxidative modifications of LDL by CuSO(4) or by amphotericin B proceed through different mechanisms.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10620711     DOI: 10.1016/s0014-5793(99)01731-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  Protective action on human LDL against oxidation and glycation by four organosulfur compounds derived from garlic.

Authors:  Chu-Chyn Ou; Shyh-Ming Tsao; Ming-Cheng Lin; Mei-Chin Yin
Journal:  Lipids       Date:  2003-03       Impact factor: 1.880

2.  Toxicity and antileishmanial activity of a new stable lipid suspension of amphotericin B.

Authors:  Malika Larabi; Vanessa Yardley; Philippe M Loiseau; Martine Appel; Philippe Legrand; Annette Gulik; Christian Bories; Simon L Croft; Gillian Barratt
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

3.  Effect of Amphotericin B Nanodisks on Leishmania major Infected Mice.

Authors:  Pa Cole; Jv Bishop; Ja Beckstead; R Titus; Ro Ryan
Journal:  Pharm Anal Acta       Date:  2014

Review 4.  Recent progress in the study of the interactions of amphotericin B with cholesterol and ergosterol in lipid environments.

Authors:  Daniel Michał Kamiński
Journal:  Eur Biophys J       Date:  2014-08-31       Impact factor: 1.733

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.